nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—Niflumic Acid—PLA2G4A—metabolic syndrome X	0.0316	0.828	CrCbGaD
Leflunomide—Appetite absent—Metformin—metabolic syndrome X	0.0181	0.0627	CcSEcCtD
Leflunomide—Nail disorder—Metformin—metabolic syndrome X	0.0139	0.0481	CcSEcCtD
Leflunomide—DHODH—adipose tissue—metabolic syndrome X	0.0118	0.169	CbGeAlD
Leflunomide—Blood disorder—Metformin—metabolic syndrome X	0.0108	0.0373	CcSEcCtD
Leflunomide—Contusion—Metformin—metabolic syndrome X	0.0103	0.0358	CcSEcCtD
Leflunomide—PTK2B—cardiovascular system—metabolic syndrome X	0.00847	0.122	CbGeAlD
Leflunomide—PTK2B—kidney—metabolic syndrome X	0.00829	0.119	CbGeAlD
Leflunomide—DHODH—liver—metabolic syndrome X	0.00827	0.119	CbGeAlD
Leflunomide—PTK2B—adipose tissue—metabolic syndrome X	0.00747	0.107	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—metabolic syndrome X	0.00659	0.173	CrCbGaD
Leflunomide—Migraine—Metformin—metabolic syndrome X	0.00643	0.0223	CcSEcCtD
Leflunomide—AHR—adipose tissue—metabolic syndrome X	0.00614	0.0882	CbGeAlD
Leflunomide—Liver function test abnormal—Metformin—metabolic syndrome X	0.00603	0.0209	CcSEcCtD
Leflunomide—Breast disorder—Metformin—metabolic syndrome X	0.0059	0.0205	CcSEcCtD
Leflunomide—Cramp muscle—Metformin—metabolic syndrome X	0.00588	0.0204	CcSEcCtD
Leflunomide—Influenza—Metformin—metabolic syndrome X	0.00564	0.0196	CcSEcCtD
Leflunomide—Pancreatitis—Metformin—metabolic syndrome X	0.00553	0.0192	CcSEcCtD
Leflunomide—Angina pectoris—Metformin—metabolic syndrome X	0.0055	0.0191	CcSEcCtD
Leflunomide—Sweating increased—Metformin—metabolic syndrome X	0.0055	0.0191	CcSEcCtD
Leflunomide—Neutropenia—Metformin—metabolic syndrome X	0.00528	0.0183	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00524	0.0182	CcSEcCtD
Leflunomide—PTK2B—liver—metabolic syndrome X	0.00524	0.0752	CbGeAlD
Leflunomide—Infestation NOS—Metformin—metabolic syndrome X	0.00503	0.0175	CcSEcCtD
Leflunomide—Infestation—Metformin—metabolic syndrome X	0.00503	0.0175	CcSEcCtD
Leflunomide—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00493	0.0171	CcSEcCtD
Leflunomide—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00476	0.0165	CcSEcCtD
Leflunomide—Rhinitis—Metformin—metabolic syndrome X	0.00453	0.0157	CcSEcCtD
Leflunomide—Hepatitis—Metformin—metabolic syndrome X	0.00452	0.0157	CcSEcCtD
Leflunomide—Oedema peripheral—Metformin—metabolic syndrome X	0.00445	0.0154	CcSEcCtD
Leflunomide—Connective tissue disorder—Metformin—metabolic syndrome X	0.00444	0.0154	CcSEcCtD
Leflunomide—AHR—liver—metabolic syndrome X	0.00431	0.0618	CbGeAlD
Leflunomide—Eye disorder—Metformin—metabolic syndrome X	0.00422	0.0146	CcSEcCtD
Leflunomide—Cardiac disorder—Metformin—metabolic syndrome X	0.00419	0.0145	CcSEcCtD
Leflunomide—Immune system disorder—Metformin—metabolic syndrome X	0.00408	0.0141	CcSEcCtD
Leflunomide—Mediastinal disorder—Metformin—metabolic syndrome X	0.00407	0.0141	CcSEcCtD
Leflunomide—Chills—Metformin—metabolic syndrome X	0.00405	0.0141	CcSEcCtD
Leflunomide—Malnutrition—Metformin—metabolic syndrome X	0.00393	0.0136	CcSEcCtD
Leflunomide—Flatulence—Metformin—metabolic syndrome X	0.00387	0.0134	CcSEcCtD
Leflunomide—Dysgeusia—Metformin—metabolic syndrome X	0.00385	0.0134	CcSEcCtD
Leflunomide—Muscle spasms—Metformin—metabolic syndrome X	0.00378	0.0131	CcSEcCtD
Leflunomide—Vision blurred—Metformin—metabolic syndrome X	0.0037	0.0129	CcSEcCtD
Leflunomide—Ill-defined disorder—Metformin—metabolic syndrome X	0.00365	0.0127	CcSEcCtD
Leflunomide—Malaise—Metformin—metabolic syndrome X	0.00355	0.0123	CcSEcCtD
Leflunomide—Palpitations—Metformin—metabolic syndrome X	0.00347	0.0121	CcSEcCtD
Leflunomide—Hypertension—Metformin—metabolic syndrome X	0.00339	0.0118	CcSEcCtD
Leflunomide—Chest pain—Metformin—metabolic syndrome X	0.00335	0.0116	CcSEcCtD
Leflunomide—Myalgia—Metformin—metabolic syndrome X	0.00335	0.0116	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00332	0.0115	CcSEcCtD
Leflunomide—Discomfort—Metformin—metabolic syndrome X	0.00331	0.0115	CcSEcCtD
Leflunomide—Infection—Metformin—metabolic syndrome X	0.00319	0.0111	CcSEcCtD
Leflunomide—Nervous system disorder—Metformin—metabolic syndrome X	0.00315	0.0109	CcSEcCtD
Leflunomide—Thrombocytopenia—Metformin—metabolic syndrome X	0.00314	0.0109	CcSEcCtD
Leflunomide—Skin disorder—Metformin—metabolic syndrome X	0.00312	0.0108	CcSEcCtD
Leflunomide—Hyperhidrosis—Metformin—metabolic syndrome X	0.0031	0.0108	CcSEcCtD
Leflunomide—Anorexia—Metformin—metabolic syndrome X	0.00306	0.0106	CcSEcCtD
Leflunomide—Hypotension—Metformin—metabolic syndrome X	0.003	0.0104	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00292	0.0101	CcSEcCtD
Leflunomide—Paraesthesia—Metformin—metabolic syndrome X	0.00288	0.00999	CcSEcCtD
Leflunomide—Dyspnoea—Metformin—metabolic syndrome X	0.00286	0.00992	CcSEcCtD
Leflunomide—Dyspepsia—Metformin—metabolic syndrome X	0.00282	0.0098	CcSEcCtD
Leflunomide—Decreased appetite—Metformin—metabolic syndrome X	0.00279	0.00967	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00277	0.00961	CcSEcCtD
Leflunomide—Fatigue—Metformin—metabolic syndrome X	0.00277	0.0096	CcSEcCtD
Leflunomide—Constipation—Metformin—metabolic syndrome X	0.00274	0.00952	CcSEcCtD
Leflunomide—Feeling abnormal—Metformin—metabolic syndrome X	0.00264	0.00917	CcSEcCtD
Leflunomide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00262	0.0091	CcSEcCtD
Leflunomide—Urticaria—Metformin—metabolic syndrome X	0.00255	0.00884	CcSEcCtD
Leflunomide—Abdominal pain—Metformin—metabolic syndrome X	0.00254	0.0088	CcSEcCtD
Leflunomide—CYP2C9—cardiovascular system—metabolic syndrome X	0.00247	0.0354	CbGeAlD
Leflunomide—ABCG2—adipose tissue—metabolic syndrome X	0.00238	0.0342	CbGeAlD
Leflunomide—Asthenia—Metformin—metabolic syndrome X	0.0023	0.00799	CcSEcCtD
Leflunomide—Pruritus—Metformin—metabolic syndrome X	0.00227	0.00787	CcSEcCtD
Leflunomide—Diarrhoea—Metformin—metabolic syndrome X	0.0022	0.00761	CcSEcCtD
Leflunomide—Dizziness—Metformin—metabolic syndrome X	0.00212	0.00736	CcSEcCtD
Leflunomide—Vomiting—Metformin—metabolic syndrome X	0.00204	0.00708	CcSEcCtD
Leflunomide—Rash—Metformin—metabolic syndrome X	0.00202	0.00702	CcSEcCtD
Leflunomide—Dermatitis—Metformin—metabolic syndrome X	0.00202	0.00701	CcSEcCtD
Leflunomide—Headache—Metformin—metabolic syndrome X	0.00201	0.00697	CcSEcCtD
Leflunomide—Nausea—Metformin—metabolic syndrome X	0.00191	0.00661	CcSEcCtD
Leflunomide—ABCG2—liver—metabolic syndrome X	0.00167	0.024	CbGeAlD
Leflunomide—CYP1A2—liver—metabolic syndrome X	0.00161	0.0231	CbGeAlD
Leflunomide—CYP2C9—liver—metabolic syndrome X	0.00153	0.0219	CbGeAlD
Leflunomide—DHODH—Metabolism—LPL—metabolic syndrome X	0.000833	0.00138	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—AKT1—metabolic syndrome X	0.000821	0.00136	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CD36—metabolic syndrome X	0.000791	0.00131	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—metabolic syndrome X	0.000775	0.00128	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—metabolic syndrome X	0.000769	0.00127	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PLA2G6—metabolic syndrome X	0.000749	0.00124	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PPARA—metabolic syndrome X	0.000736	0.00122	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—metabolic syndrome X	0.000732	0.00121	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GGT1—metabolic syndrome X	0.000717	0.00119	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—AKT1—metabolic syndrome X	0.000715	0.00118	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—AGT—metabolic syndrome X	0.000712	0.00118	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—APOE—metabolic syndrome X	0.000698	0.00116	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—APOA1—metabolic syndrome X	0.00069	0.00114	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TRIB3—metabolic syndrome X	0.000689	0.00114	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—AKT1—metabolic syndrome X	0.000675	0.00112	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000614	0.00102	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PPARG—metabolic syndrome X	0.000608	0.00101	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—INS—metabolic syndrome X	0.000596	0.000987	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000593	0.000982	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—AKT1—metabolic syndrome X	0.000564	0.000934	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—metabolic syndrome X	0.000561	0.000929	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ALB—metabolic syndrome X	0.000547	0.000905	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CYBA—metabolic syndrome X	0.000533	0.000883	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000525	0.000869	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NOS3—metabolic syndrome X	0.000523	0.000866	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—AKT1—metabolic syndrome X	0.000513	0.00085	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000511	0.000847	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GGT1—metabolic syndrome X	0.000491	0.000813	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	0.000489	0.00081	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000489	0.00081	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—FMO3—metabolic syndrome X	0.000484	0.000801	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGS2—metabolic syndrome X	0.000478	0.000792	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000471	0.00078	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000457	0.000757	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000455	0.000753	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RBP4—metabolic syndrome X	0.000445	0.000738	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000445	0.000738	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—VCAM1—metabolic syndrome X	0.000433	0.000718	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MLXIPL—metabolic syndrome X	0.000431	0.000714	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—EPHX2—metabolic syndrome X	0.000431	0.000714	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	0.00042	0.000695	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000418	0.000692	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.000405	0.000671	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—G6PC2—metabolic syndrome X	0.000405	0.000671	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOC3—metabolic syndrome X	0.000395	0.000653	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000391	0.000647	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL18—metabolic syndrome X	0.000383	0.000635	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.000379	0.000627	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.000379	0.000627	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000371	0.000614	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000367	0.000607	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	0.000359	0.000594	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000356	0.00059	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD36—metabolic syndrome X	0.000356	0.00059	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CYBA—metabolic syndrome X	0.000345	0.000571	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—FABP4—metabolic syndrome X	0.000345	0.000571	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GHRL—metabolic syndrome X	0.000338	0.000559	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000334	0.000553	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HSD11B1—metabolic syndrome X	0.000327	0.000541	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000322	0.000534	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—metabolic syndrome X	0.000321	0.000532	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CNR1—metabolic syndrome X	0.00032	0.000529	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000317	0.000524	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000315	0.000522	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000305	0.000505	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000302	0.0005	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000301	0.000499	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—G6PD—metabolic syndrome X	0.000291	0.000482	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HDAC3—metabolic syndrome X	0.000284	0.000471	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000281	0.000465	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRS1—metabolic syndrome X	0.00028	0.000464	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LPA—metabolic syndrome X	0.000278	0.00046	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GCKR—metabolic syndrome X	0.000278	0.00046	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000276	0.000456	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000269	0.000446	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLA2G6—metabolic syndrome X	0.000269	0.000446	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOA5—metabolic syndrome X	0.000266	0.000441	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF2—metabolic syndrome X	0.000261	0.000433	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000261	0.000432	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000258	0.000428	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000254	0.000421	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOB—metabolic syndrome X	0.000254	0.00042	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.00025	0.000415	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000249	0.000412	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL5—metabolic syndrome X	0.000248	0.00041	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TRIB3—metabolic syndrome X	0.000248	0.00041	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000247	0.000409	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FMO3—metabolic syndrome X	0.000244	0.000405	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LPL—metabolic syndrome X	0.000242	0.000401	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000242	0.0004	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—AKT1—metabolic syndrome X	0.00024	0.000398	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.00024	0.000397	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000238	0.000395	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000231	0.000383	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000225	0.000372	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NAMPT—metabolic syndrome X	0.000222	0.000368	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LIPC—metabolic syndrome X	0.000221	0.000366	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GCK—metabolic syndrome X	0.000221	0.000366	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOC3—metabolic syndrome X	0.000219	0.000363	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000218	0.000362	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	0.000218	0.000361	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	0.000218	0.000361	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000214	0.000354	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CETP—metabolic syndrome X	0.000213	0.000353	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000213	0.000352	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FMO3—metabolic syndrome X	0.000209	0.000346	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AGT—metabolic syndrome X	0.000207	0.000343	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000206	0.000342	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	0.000205	0.000339	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SCARB1—metabolic syndrome X	0.000204	0.000338	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—metabolic syndrome X	0.000203	0.000336	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOE—metabolic syndrome X	0.000203	0.000336	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOA1—metabolic syndrome X	0.000201	0.000332	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SREBF1—metabolic syndrome X	0.000198	0.000328	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000198	0.000327	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000195	0.000322	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT2—metabolic syndrome X	0.000193	0.000319	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMGCR—metabolic syndrome X	0.000193	0.000319	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000192	0.000318	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000189	0.000313	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000189	0.000312	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000187	0.000309	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	0.000186	0.000308	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	0.000186	0.000308	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IRS1—metabolic syndrome X	0.000181	0.0003	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	0.000175	0.00029	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FABP4—metabolic syndrome X	0.000174	0.000288	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INS—metabolic syndrome X	0.000173	0.000287	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCA1—metabolic syndrome X	0.000172	0.000284	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SLC2A4—metabolic syndrome X	0.000172	0.000284	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL2—metabolic syndrome X	0.000171	0.000283	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1—metabolic syndrome X	0.000168	0.000278	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000166	0.000276	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT1—metabolic syndrome X	0.000166	0.000275	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGT1—metabolic syndrome X	0.000166	0.000275	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	0.000165	0.000273	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000161	0.000267	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.00016	0.000265	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000159	0.000264	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000156	0.000258	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000153	0.000253	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—metabolic syndrome X	0.000152	0.000252	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FABP4—metabolic syndrome X	0.000149	0.000246	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—G6PD—metabolic syndrome X	0.000147	0.000244	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000145	0.00024	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	0.000144	0.000238	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOB—metabolic syndrome X	0.000141	0.000234	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	0.000141	0.000234	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPA—metabolic syndrome X	0.00014	0.000232	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCKR—metabolic syndrome X	0.00014	0.000232	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLA2G4A—metabolic syndrome X	0.000137	0.000227	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000137	0.000226	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	0.000136	0.000225	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000135	0.000223	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LPL—metabolic syndrome X	0.000135	0.000223	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA5—metabolic syndrome X	0.000135	0.000223	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000133	0.00022	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000131	0.000216	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000131	0.000216	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000128	0.000212	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CD36—metabolic syndrome X	0.000128	0.000212	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000127	0.00021	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—G6PD—metabolic syndrome X	0.000126	0.000208	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	0.000125	0.000207	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000124	0.000205	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	0.000123	0.000203	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCKR—metabolic syndrome X	0.00012	0.000199	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPA—metabolic syndrome X	0.00012	0.000199	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARA—metabolic syndrome X	0.000119	0.000197	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—metabolic syndrome X	0.000117	0.000194	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	0.000116	0.000192	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000115	0.000191	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AGT—metabolic syndrome X	0.000115	0.000191	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA5—metabolic syndrome X	0.000115	0.00019	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—metabolic syndrome X	0.000113	0.000187	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	0.000112	0.000186	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000112	0.000185	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOA1—metabolic syndrome X	0.000112	0.000185	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000112	0.000185	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LIPC—metabolic syndrome X	0.000111	0.000185	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCK—metabolic syndrome X	0.000111	0.000185	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOC3—metabolic syndrome X	0.000111	0.000183	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000109	0.000181	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000108	0.000179	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AKT1—metabolic syndrome X	0.000108	0.000179	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CETP—metabolic syndrome X	0.000108	0.000178	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	0.000107	0.000177	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	0.000103	0.000171	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—metabolic syndrome X	0.000101	0.000167	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.0001	0.000166	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	0.0001	0.000166	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—metabolic syndrome X	9.83e-05	0.000163	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	9.73e-05	0.000161	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT2—metabolic syndrome X	9.73e-05	0.000161	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—metabolic syndrome X	9.65e-05	0.00016	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	9.59e-05	0.000159	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	9.53e-05	0.000158	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LIPC—metabolic syndrome X	9.53e-05	0.000158	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCK—metabolic syndrome X	9.53e-05	0.000158	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOC3—metabolic syndrome X	9.47e-05	0.000157	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CETP—metabolic syndrome X	9.19e-05	0.000152	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—metabolic syndrome X	8.84e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	8.8e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.77e-05	0.000145	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	8.67e-05	0.000144	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	8.67e-05	0.000144	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	8.57e-05	0.000142	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	8.55e-05	0.000142	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—metabolic syndrome X	8.46e-05	0.00014	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT1—metabolic syndrome X	8.4e-05	0.000139	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT1—metabolic syndrome X	8.4e-05	0.000139	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	8.31e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT2—metabolic syndrome X	8.31e-05	0.000138	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—metabolic syndrome X	7.74e-05	0.000128	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—metabolic syndrome X	7.58e-05	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	7.5e-05	0.000124	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	7.41e-05	0.000123	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	7.41e-05	0.000123	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT1—metabolic syndrome X	7.18e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT1—metabolic syndrome X	7.18e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOB—metabolic syndrome X	7.13e-05	0.000118	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT1—metabolic syndrome X	6.99e-05	0.000116	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	6.93e-05	0.000115	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPL—metabolic syndrome X	6.8e-05	0.000113	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CD36—metabolic syndrome X	6.46e-05	0.000107	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOB—metabolic syndrome X	6.09e-05	0.000101	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARA—metabolic syndrome X	6.01e-05	9.95e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	5.92e-05	9.81e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AGT—metabolic syndrome X	5.82e-05	9.64e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPL—metabolic syndrome X	5.81e-05	9.63e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—metabolic syndrome X	5.7e-05	9.44e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA1—metabolic syndrome X	5.64e-05	9.34e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CD36—metabolic syndrome X	5.52e-05	9.15e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARA—metabolic syndrome X	5.14e-05	8.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AGT—metabolic syndrome X	4.97e-05	8.24e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—metabolic syndrome X	4.97e-05	8.23e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—metabolic syndrome X	4.87e-05	8.07e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—metabolic syndrome X	4.87e-05	8.07e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA1—metabolic syndrome X	4.82e-05	7.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—metabolic syndrome X	4.47e-05	7.4e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—metabolic syndrome X	4.27e-05	7.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—metabolic syndrome X	4.24e-05	7.03e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—metabolic syndrome X	4.16e-05	6.89e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	3.91e-05	6.47e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKT1—metabolic syndrome X	3.89e-05	6.44e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—metabolic syndrome X	3.82e-05	6.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—metabolic syndrome X	3.65e-05	6.05e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	3.34e-05	5.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.96e-05	3.25e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.68e-05	2.78e-05	CbGpPWpGaD
